Oregon Recalls THC Vape Pods Containing Unapproved Additives

Aug.24.2022
Oregon Recalls THC Vape Pods Containing Unapproved Additives
18,000 THC e-cigarette pods recalled in Oregon due to unauthorized non-cannabis additives, potentially causing respiratory issues.

During an investigation conducted by the Oregon Liquor Control Commission (OLCC) this month, it was found that over 18,000 THC (tetrahydrocannabinol) electronic cigarette pods sold in Oregon between November 2021 and July 2022 contained unapproved non-cannabis additives, which could potentially pose health issues for the respiratory system.


Here is what the recall for the electronic cigarettes shopping cart label looks like:


The marijuana regulatory agency in the state of Oregon has issued a recall for 18,000 electronic THC vape pods manufactured by YHN. The recall notice is printed on the back of the packaging (as shown in the photo from OLCC). The OLCC has initiated the recall of these pods, which were manufactured by YHN and sold in two stores located in the eastern Oregon town of Ontario.


Weedology and The Bud House are two pharmacies in Ontario that sell electronic cigarette pods. They have voluntarily pulled the recalled YHN products from their shelves. So far, the OLCC has not received any reports from consumers who have experienced negative health effects from using these YHN products.


We encourage consumers who have purchased unapproved products to return them to OLCC-licensed retailers or dispose of them. Individuals who have health concerns regarding recalled e-cigarette products should contact their healthcare provider.


The main culprit: Soybean oil.


As part of their ongoing independent investigation, officials from the OLCC tested a range of products from the YHN brand and found that some of their flavoring cartridges for inhalable cannabis may contain soybean oil, which contains triglycerides of glycerol and is prohibited for use in e-cigarette products in Oregon.


Soybean oil is considered a generally recognized as safe (GRAS) food additive by the U.S. Food and Drug Administration. However, this classification is based on ingestion rather than inhalation. When soybean oil is heated into vapor and inhaled, the triglycerides in it may cause various long and short-term health problems, including lipoid pneumonia, a rare lung disease that can cause lung inflammation and breathing difficulties.


Risk: Lipoid Pneumonia


According to data from the National Institutes of Health in the United States, the incidence of lipoid pneumonia is increasing with the rise of nicotine and tetrahydrocannabinol (THC) electronic cigarettes.


According to the National Institutes of Health, an electronic cigarette is defined as a device that uses heat to produce aerosol inhaled by the user from a liquid containing various chemicals, including but not limited to nicotine, artificial flavors, or marijuana. Their guidelines were last updated as of June 2022. A series of cases completed in North Carolina observed five previously healthy individuals who had no underlying conditions, experienced acute respiratory failure requiring hospitalization, and were found to frequently expose themselves to vaporized aerosol in July and August 2019.


In 2019, a vaping-related lung illness known as EVALI resulted in 60 deaths and over 2,800 hospitalizations. This illness was caused by the use of illegal THC vape pods containing vitamin E oil. While this oil has FDA approval for use in a variety of products, it is not suitable for inhalation via vaporization. In response to the EVALI outbreak, Oregon and other legal cannabis states have implemented strict regulations prohibiting certain additives such as vitamin E oil, squalene, and propylene glycol in cannabis vape pods.


Health risks associated with inhaling soybean oil have been observed in both food seasoning and production factories. In 2002, a microwave popcorn factory experienced a mysterious outbreak of bronchiolitis obliterans. Officials investigating the incident at the Centers for Disease Control and Prevention found that workers in the factory had lung problems caused by inhaling aerosolized byproducts of heated soybean oil.


Further punishment will depend on the intent of the production.


In the OLCC investigation into YHN's vape pod, flavors such as "Fruit Blend" and "Green Crack" were tested. Independent testing revealed the presence of ingredients that match those found in soybean oil, a substance banned for use in e-cigarettes in Oregon. It was also discovered that YHN's labeling only partially complied with Oregon's regulations for inhalable cannabinoid products.


The ingredient list of the YHN e-cigarette products that were recalled did indeed include artificial flavorings, and the products were correctly classified according to OLCC rules. However, YHN did not follow OLCC requirements to further break down the ingredients in their artificial flavorings to disclose the presence of soybean oil.


YHN may face a fine of $4,950 or have their marijuana license revoked. These are two very different outcomes, and the punishment may depend on whether OLCC determines that the prohibited additives were intentionally added or due to negligent oversight.


Announcement:


This article has been compiled from third-party information and is intended for industry communication and learning purposes only.


This article does not represent the viewpoint of 2FIRSTS, and 2FIRSTS is unable to confirm the authenticity and accuracy of the article's content. The article's translation is only intended for communication and research within the industry.


Due to limitations in the translator's proficiency, the compiled article may not express the same meaning as the original text. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the position and statements of the Chinese government in relation to any issues pertaining to domestic affairs, Hong Kong, Macau, Taiwan, and foreign affairs.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Surrey councillor calls for tougher vape sales controls, seeking the “most restrictive legally supportable” package
Surrey councillor calls for tougher vape sales controls, seeking the “most restrictive legally supportable” package
Surrey Councillor Gordon Hepner presented a notice of motion calling on council to “wage war on vaping” by strengthening controls on the sale of vaping products in the city, citing vaping as a “serious health concern,” especially among youth. Hepner said the motion directs staff to bring back the “most restrictive legally supportable” package from the City’s 2019 bylaw work to materially reduce where and how vape products can be sold, including licensing controls and enforcement.
Feb.10 by 2FIRSTS.ai
Federal Register notice: FDA seeks comments on “Warning Plans for Certain Tobacco Products”
Federal Register notice: FDA seeks comments on “Warning Plans for Certain Tobacco Products”
The U.S. Food and Drug Administration (FDA) issued a notice stating it has submitted a proposed information collection to the Office of Management and Budget (OMB) for review under the Paperwork Reduction Act.
Jan.16 by 2FIRSTS.ai
Product | ON! PLUS: Breakdown of Six FDA-PMTA-Authorized Nicotine Pouches—6/9 mg Strengths, Slim Format, and Traditional Flavours
Product | ON! PLUS: Breakdown of Six FDA-PMTA-Authorized Nicotine Pouches—6/9 mg Strengths, Slim Format, and Traditional Flavours
The U.S. FDA has added six ON!® PLUS nicotine pouch products to its list of Marketing Granted Order (MGO) authorizations. Based on 2Firsts’ review, the approved products feature a highly standardized configuration in terms of format, nicotine strength, and flavour portfolio, primarily focusing on 6 mg and 9 mg strengths and traditional variants such as mint, wintergreen, and tobacco—reflecting a clear compliance-oriented approach.
Dec.22 by 2FIRSTS.ai
Russian Region Targets Youth Vaping and Night Alcohol Sales
Russian Region Targets Youth Vaping and Night Alcohol Sales
The Speaker of the Legislative Assembly of Russia’s Nizhny Novgorod Region said efforts to curb night-time alcohol sales and the spread of e-cigarettes will continue in 2026. While illegal alcohol trade has largely been eliminated, youth vaping remains a major concern. Regional authorities are seeking federal approval to allow local governments to impose stricter restrictions on vape sales, alongside increased health education initiatives.
Dec.22 by 2FIRSTS.ai
2Firsts Flash|PMI Reports 2025 Results as Smoke-Free Products Account for 41.5% of Net Revenues
2Firsts Flash|PMI Reports 2025 Results as Smoke-Free Products Account for 41.5% of Net Revenues
Philip Morris International reported full-year 2025 results on February 6, with smoke-free products accounting for 41.5% of adjusted net revenues, up from 38.7% a year earlier. Total net revenues rose 7.3% to $40.65 billion, while shipment volumes increased 1.4%, widening the gap between revenue and volume growth. Cigarette shipments declined as smoke-free volumes rose 12.8%, driven by heated tobacco, oral nicotine and e-vapor products. Results were released alongside a 9:00 a.m. EST webcast.
Feb.06
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
During the “Toxicological Profile” session at FDA’s Feb 10 PMTA roundtable, officials outlined the carcinogenicity tiering system and Excess Lifetime Cancer Risk (ELCR) framework used in ENDS reviews under the APPH standard. Small manufacturers questioned database transparency, exposure assumptions, and the existence of clear compliance benchmarks. FDA reiterated toxicological risk is assessed case by case within a broader population-level determination.
Feb.11